Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
295M
-
Number of holders
-
216
-
Total 13F shares, excl. options
-
64.6M
-
Shares change
-
+13.2K
-
Total reported value, excl. options
-
$1.1B
-
Value change
-
+$6.26M
-
Put/Call ratio
-
0.88
-
Number of buys
-
107
-
Number of sells
-
-83
-
Price
-
$16.95
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q3 2018
264 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q3 2018.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 216 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.6M shares
of 295M outstanding shares and own 21.93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.32M shares), Vanguard Group Inc (7.48M shares), STATE STREET CORP (6.51M shares), WASATCH ADVISORS INC (4.54M shares), FMR LLC (2.66M shares), CREDIT SUISSE AG/ (2.18M shares), Casdin Capital, LLC (2M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.4M shares), NORTHERN TRUST CORP (1.32M shares), and BAKER BROS. ADVISORS LP (1.28M shares).
This table shows the top 216 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.